Updates in treatment and impact of nail psoriasis

被引:8
作者
Iorizzo, Matilde [2 ]
Tosti, Antonella [1 ]
机构
[1] Univ Miami, Miller Sch Med, Dept Dermatol & Cutaneous Surg, Miami, FL USA
[2] Viale Stn 16, CH-6500 Bellinzona, Switzerland
关键词
Nail disorders; nail psoriasis; psoriasis; quality of life; treatment; treatment update; QUALITY-OF-LIFE; CHRONIC PLAQUE PSORIASIS; JANUS KINASE INHIBITOR; PULSED DYE-LASER; DOUBLE-BLIND; BETAMETHASONE DIPROPIONATE; FINGERNAIL PSORIASIS; STEROID INJECTION; SEVERITY; EFFICACY;
D O I
10.1080/1744666X.2023.2215987
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
IntroductionNail psoriasis is an inflammatory disorder without a potential scarring outcome, but the nail signs, even the milder ones, can cause discomfort to patients and severely affect their quality of life. Nail psoriasis may be associated with psoriatic arthritis and when it starts during infancy, it may be a predictor of a more severe disease course in adulthood. All these issues contribute to the high economic burden of psoriasis.Areas coveredNail psoriasis is notoriously difficult to treat, even though new treatments are in continuous development. This paper provides an update on new treatments and address the current gaps in care of nail psoriasis.Expert opinionA better understanding of the disease pathogenesis and more 'real-life' studies will definitely be helpful to improve treatment results. A lower level of heterogeneity should be advisable among trials when evaluating nail psoriasis. Moreover, the relationship between nail psoriasis and psoriatic arthritis should be the focus of unbiased studies in order to better define the real risk that nail psoriasis patients have to develop arthritis.
引用
收藏
页码:1091 / 1100
页数:10
相关论文
共 106 条
[1]   Interobserver reliability of the Nail Psoriasis Severity Index [J].
Aktan, S. ;
Ilknur, T. ;
Akin, C. ;
Ozkan, S. .
CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2007, 32 (02) :141-144
[2]  
Arango-Duque LC, 2017, ACTAS DERMO-SIFILOGR, V108, P140, DOI [10.1016/j.adengl.2016.09.015, 10.1016/j.ad.2016.09.009]
[3]   Deucravacitinib versus placebo and apremilast in moderate to severe plaque psoriasis: Efficacy and safety results from the 52-week, randomized, double-blinded, placebo-controlled phase 3 POETYK PSO-1 trial [J].
Armstrong, April W. ;
Gooderham, Melinda ;
Warren, Richard B. ;
Papp, Kim A. ;
Strober, Bruce ;
Thaci, Diamant ;
Morita, Akimichi ;
Szepietowski, Jacek C. ;
Imafuku, Shinichi ;
Colston, Elizabeth ;
Throup, John ;
Kundu, Sudeep ;
Schoenfeld, Steve ;
Linaberry, Misti ;
Banerjee, Subhashis ;
Blauvelt, Andrew .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 88 (01) :29-39
[4]   Nail psoriasis in Germany: epidemiology and burden of disease [J].
Augustin, M. ;
Reich, K. ;
Blome, C. ;
Schaefer, I. ;
Laass, A. ;
Radtke, M. A. .
BRITISH JOURNAL OF DERMATOLOGY, 2010, 163 (03) :580-585
[5]   Tofacitinib: A New Oral Therapy for Psoriasis [J].
Azevedo, Alexandra ;
Torres, Tiago .
CLINICAL DRUG INVESTIGATION, 2018, 38 (02) :101-112
[6]   Small molecule mediated inhibition of RORγ-dependent gene expression and autoimmune disease pathology in vivo [J].
Banerjee, Daliya ;
Zhao, Linlin ;
Wu, Lan ;
Palanichamy, Arumugam ;
Ergun, Ayla ;
Peng, Liaomin ;
Quigley, Catherine ;
Hamann, Stefan ;
Dunstan, Robert ;
Cullen, Patrick ;
Allaire, Norm ;
Guertin, Kevin ;
Wang, Tao ;
Chao, Jian-Hua ;
Loh, Christine ;
Fontenot, Jason D. .
IMMUNOLOGY, 2016, 147 (04) :399-413
[7]   Proximal nail fold intralesional steroid injection responsible for Hoigne syndrome [J].
Baran, R. .
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2014, 28 (11) :1563-1565
[8]  
Blauvelt A., 2019, SKIN J CUTANEOUS MED, V3, P34
[9]   Patient-relevant needs and treatment goals in nail psoriasis [J].
Blome, C. ;
Costanzo, A. ;
Dauden, E. ;
Ferrandiz, C. ;
Girolomoni, G. ;
Gniadecki, R. ;
Iversen, L. ;
Menter, A. ;
Michaelis-Wittern, K. ;
Morita, A. ;
Nakagawa, H. ;
Reich, K. ;
Augustin, M. .
QUALITY OF LIFE RESEARCH, 2016, 25 (05) :1179-1188
[10]   Treatment of nail psoriasis with topical application of clobetasol propionate 0.05% solution: a pilot study [J].
Brandi, Nicolo ;
Starace, Michela ;
Alessandrini, Aurora ;
Bruni, Francesca ;
Piraccini, Bianca Maria .
EUROPEAN JOURNAL OF DERMATOLOGY, 2018, 28 (01) :111-112